S100P Antibody

中文名稱：

S100P兔多克隆抗體
貨號(hào)：

CSB-PA020645LA01HU
規(guī)格：

￥440
圖片：
Immunohistochemistry of paraffin-embedded human pancreatic cancer using CSB-PA020645LA01HU at dilution of 1:100

Immunofluorescent analysis of HepG2 cells using CSB-PA020645LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) S100P Polyclonal antibody
Uniprot No.：

P25815
基因名：

S100P
別名：

MIG9 antibody; Migration inducing gene 9 antibody; Protein S100-E antibody; Protein S100-P antibody; Protein S100P antibody; S100 calcium binding protein P antibody; S100 calcium-binding protein P antibody; S100 P antibody; S100E antibody; S100P antibody; S100P_HUMAN antibody
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Recombinant Human Protein S100-P protein (17-70AA)
免疫原種屬：

Homo sapiens (Human)

標(biāo)記方式：

Non-conjugated

本頁(yè)面中的產(chǎn)品，S100P Antibody (CSB-PA020645LA01HU)，的標(biāo)記方式是Non-conjugated。對(duì)于S100P Antibody，我們還提供其他標(biāo)記。見下表：

標(biāo)記方式	貨號(hào)	產(chǎn)品名稱	應(yīng)用
HRP	CSB-PA020645LB01HU	S100P Antibody, HRP conjugated	ELISA
FITC	CSB-PA020645LC01HU	S100P Antibody, FITC conjugated
Biotin	CSB-PA020645LD01HU	S100P Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, IHC, IF

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200
IF	1:50-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
Immunofluorescence (IF) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

May function as calcium sensor and contribute to cellular calcium signaling. In a calcium-dependent manner, functions by interacting with other proteins, such as EZR and PPP5C, and indirectly plays a role in physiological processes like the formation of microvilli in epithelial cells. May stimulate cell proliferation in an autocrine manner via activation of the receptor for activated glycation end products (RAGE).
基因功能參考文獻(xiàn)：
1. Data suggest that analysis of S100P concentration in duodenal fluid (DF), in combination with routine screening upper gastrointestinal endoscopy (GIE), may facilitate the detection of pancreatic ductal adenocarcinoma (PDAC). PMID: 28984789
2. Data show that inhibition of S100 calcium binding protein P (S100P) results in reversing trastuzumab resistance (TzR) in proto-oncogene protein HER-2 (HER2)-driven breast cancers. PMID: 27449296
3. the S100P protein may contribute to the outgrowth of aggressive tumor cells resistant to cytotoxic therapy and promote cancer progression. PMID: 26967060
4. Results found high plasma levels of S100P protein in patients with metastatic breast cancer which suggest its implication in disease progression. PMID: 27146585
5. activation of tissue plasminogen activator via the C-terminal lysine of S100P contributes to the enhancement of cell invasion by S100P and thus potentially to its metastasis-promoting activity. PMID: 28798096
6. This study reveals significant association between blood-based decreased S100P methylation and Breast cancer (BC), and provides another proof for the application of altered DNA methylation signatures from blood cells as potential markers for the detection of BC, especially for the early stage. PMID: 28426874
7. Novel positive feedback loop between Trx-1 and S100P promotes colorectal cancer invasion and metastasis. PMID: 28483515
8. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. PMID: 27984121
9. We established a novel quantitative analysis for the S100P protein in EUS-FNA samples which, when combined with EUS-FNA cytology, could provide promising results for the reliable diagnosis of pancreatic adenocarcinoma (PCA) PMID: 28260012
10. S100P achieved 96.4% sensitivity, 93.3% specificity, 98.2% PPV, 87.5% NPV and 95.8% total accuracy, while IMP3 achieved 91.2% sensitivity, 86.7% specificity, 96.2% PPV, 72.2% NPV and 90.3% total accuracy for pancreatic ductal adenocarcinoma (PDA).Both markers were sensitive and specific for diagnosis of PDA. PMID: 27839709
11. we demonstrate that cadmium inhibits S100P expression and cell proliferation in placenta, meanwhile, S100P expression affects cell proliferation PMID: 27665374
12. Results indicate that overexpression of S100P is related with an invasive and metastatic phenotype of CRC which is EMT-involved and RAGE dependent. PMID: 26975699
13. S100P in first trimester placenta was significantly less in spontaneous abortion patients than in normal pregnant women. Up-regulation of S100P in JAR cells promoted JAR cells proliferation, and increased the expression of p38 MAPK and pERK MAPK PMID: 26291820
14. Data indicate that S100 calcium binding protein P (S100P) increased lung cancer cell migration by binding integrin alpha7. PMID: 26320193
15. Keap1 functions as a suppressor of tumor metastasis by targeting the Nrf2/S100P pathway in NSCLC cells. PMID: 26078391
16. Results suggest that SOX9 promotes tumor metastasis and invasion through regulation of S100P expression in colon cancer. PMID: 26009899
17. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway. PMID: 26797416
18. The highly specific IL-11 - S100P interaction occurring under physiologically relevant conditions should be taken into consideration upon development of the antineoplastics inhibiting IL-11 signaling. PMID: 26551460
19. S100P expression in prostate cancer tissue was significantly decreased, whereas CD147 and OCT4 expression was increased. Their expression levels were closely associated with TNM stage and distant metastasis. PMID: 26125892
20. t-S100P, 9.2-kDa C-terminally truncated form of S100P, is the predominant form of S100P in breast cancer tissue and is strongly prognostic for disease-free survival in women with lymph node-positive disease. PMID: 26276712
21. S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells PMID: 26193421
22. High expression of S100P and HYAL2 is significantly associated with advanced disease and shorter survival of triple-negative breast cancer and S100P and HYAL2 could be potential prognostic markers of TNBC. PMID: 26112095
23. upregulation of S100P expression is a predominant characteristic in polypoid CRC, whereas ulcerative CRC presents with a wide range of expression levels, indicating that S100P overexpression is not a key determinant in conferring invasion properties PMID: 25585623
24. B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway. PMID: 24681956
25. S100P may promote endometrial tumor cell proliferation by increasing nuclear translocation of beta-catenin. PMID: 24966918
26. The results suggest that S100P acts as an oncogenic factor in gastric cancer and is a potential molecular target for gastric cancer gene therapy. PMID: 24677114
27. The current evidence suggests that S100P plays an important role in the diagnosis of Pancreatic cancer with a high sensitivity and specificity [review] PMID: 25123266
28. The expression of S100P in human gastric cancer tissues was upregulated in comparison with normal controls. PMID: 23722300
29. Ectopic expression of S100P promotes SW480 cancer cells migration. PMID: 24381058
30. Use of S100P and mesothelin in cytologically borderline cases can increase the diagnostic accuracy for pancreatic adenocarcinoma. PMID: 21538952
31. Expression levels significantly higher in melanomas than in nevus pigmentosus PMID: 24303922
32. S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors. PMID: 23785431
33. S100P participates in the periodic change of the endometrium and plays an important role in embryo implantation. PMID: 23216986
34. S100P protein , human is useful as prognostic marker for extrahepatic bile duct carcinoma. PMID: 23269460
35. The expression of miR-155 is regulated by S100P and is dependent on RAGE activation and stimulation of AP-1. PMID: 23693020
36. Demonstrate that a high nuclear S100P expression level was associated with poor survival in early stage breast cancer patients. PMID: 23364898
37. S100P facilitates cancer cell intravasation/extravasation, critical steps in the hematogenous dissemination of pancreatic cancer cells PMID: 23007696
38. colorectal cancer patients with normal serum levels of S100P showed favorable prognosis compared with patients with elevated S100P levels PMID: 22552710
39. This study investigates whether there is a correlation of expression of S100P and von Hippel-Lindau gene product (pVHL) in common cystic neoplasms of the pancreas. PMID: 22585604
40. Data show wthat the S100P-induced dissociation of NMIIA filaments leads to a weakening of focal adhesion sites (FAS), reduced cell adhesion, and enhanced cell migration, the first major step in the metastatic cascade. PMID: 22399300
41. investigation of expression of S100P, S100A4, and AGR2 at cellular level within endometrium of normal fertile women across menstrual cycle and comparison with expression in eutopic and peritoneal ectopic endometrial tissue in endometriosis PMID: 22147918
42. data suggest that S100P is a direct transcriptional target of glucocorticoid-mediated signaling in tumor cells that is activated through the interplay of GR and MAPK pathways PMID: 21751241
43. Data show that knockdown of S100P led to downregulation of thioredoxin 1 and beta-tubulin and upregulation of RhoGDIA, all potential therapeutic targets in cancer. PMID: 21327297
44. Our results suggest that S100P-ezrin signaling has different roles of carcinogenesis of perihilar ICC and an aggressive course of peripheral intrahepatic cholangiocarcinoma. PMID: 21412073
45. The 5-year cumulative survival rate of patients with positive S100P expression was significantly higher than that of patients with negative expression. PMID: 21054985
46. S100P is a novel Ca(2+)-dependent regulator of IQGAP1 that can down-regulate the function of IQGAP1 as a signaling intermediate by direct interaction PMID: 21177863
47. S100P has slightly lower sensitivity and higher specificity of pancreatic ductal adenocarcinoma than XIAP in endoscopic ultrasound-guided fine needle aspirations specimens. PMID: 21325798
48. S100P may play an important role in malignant transformation of ductal cells of pleomorphic adenoma PMID: 21317706
49. High S100p is associated with colon cancer. PMID: 20890108
50. S100P is highly expressed during the implantation window in human endometrium. PMID: 19796763
顯示更多

收起更多
亞細(xì)胞定位：

Nucleus. Cytoplasm. Cell projection, microvillus membrane. Note=Colocalizes with S100PBP in the nucleus. Colocolizes with EZR in the microvilli in a calcium-dependent manner.
蛋白家族：

S-100 family
組織特異性：

Detected in all of the tissues except brain, testis and small intestine, expression level is higher in placenta, heart, lung, skeletal muscle, spleen and leukocyte. Up-regulated in various pancreatic ductal adenocarcinomas and pancreatic intraepithelial n
數(shù)據(jù)庫(kù)鏈接：

HGNC: 10504

OMIM: 600614

KEGG: hsa:6286

STRING: 9606.ENSP00000296370

UniGene: Hs.2962

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human